Autres langues CEL-SCI Corporation

Actions

CVM

US1508376076

Temps réel estimé Cboe BZX Autres places de cotation 15:54:51 14/05/2024			Varia. 5j.	Varia. 1 janv.
1,47 ^USD	+3,52%		-11,99%	-45,96%

08/05	Cel-Sci obtient l'autorisation de la FDA américaine de procéder à une étude de confirmation pour son médicament contre le cancer Multikine	MT
08/05	CEL-SCI Corporation annonce un résultat significativement positif de sa récente réunion avec la Food and Drug Administration américaine concernant la voie d'approbation de son immunothérapie expérimentale de première ligne contre le cancer, Multikine	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head and Neck Cancer	09/05
Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine	08/05
CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer	08/05
CEL-SCI Corporation Announces Significantly Positive Outcome from its Recent Meeting with U.S. Food and Drug Administration Regarding Path to Approval for its First-Line Investigational Cancer Immunotherapy Multikine	08/05
CEL-SCI Corporation Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer	08/05
CEL-SCI Appoints Mario Gobbo to Its Board of Directors	23/04
CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	23/04
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	19/03
CEL-SCI Corporation Issues Letter to Shareholders	06/03
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	15/02
Cel-Sci: Fiscal Q1 Earnings Snapshot	14/02
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	14/02
CEL-SCI Corporation (von First Berlin Equity Research GmbH...	14/02
Cel-Sci Closes $7.8 Million Share Offering	13/02
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	13/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	12/02
Health Care Slips on Rotation to High-Risk Sectors -- Health Care Roundup	10/02
Cel-Sci Prices $7.8 Million Public Offering of Common Shares	09/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	09/02
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head and Neck Cancer Drug	07/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues CEL-SCI Corporation

Actions

CVM

US1508376076

Autres langues

Filtres